Risk of Intravenous Contrast Material–mediated Acute Kidney Injury: A Propensity Score–matched Study Stratified by Baseline-estimated Glomerular Filtration Rate
Authors:
- Robert J. McDonaldRMRobert J. McDonald
- Rickey E. CarterRCRickey E. Carter
- Richard W. KatzbergRKRichard W. Katzberg
- David F. KallmesDKDavid F. Kallmes
- Eric E. WilliamsonEWEric E. Williamson
Top Cited Papers
- 1 April 2014
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 271 (1) , 65-73
Abstract
To determine the effect of baseline estimated glomerular filtration rate (eGFR) on the causal association between intravenous iodinated contrast material exposure and subsequent development of acute kidney injury (AKI) in propensity score-matched groups of patients who underwent contrast material-enhanced or unenhanced computed tomography (CT). This retrospective study was HIPAA compliant and institutional review board approved. All patients who underwent contrast-enhanced (contrast material group) or unenhanced (non-contrast material group) CT between 2000 and 2010 were identified and stratified according to baseline eGFR by using Kidney Disease Outcomes Quality Initiative cutoffs for chronic kidney disease into subgroups with eGFR of 90 or greater, 60-89, 30-59, and less than 30 mL/min/1.73 m(2). Propensity score generation and 1:1 matching of patients were performed in each eGFR subgroup. Incidence of AKI (serum creatinine [SCr] increase of ≥0.5 mg/dL [≥44.2 μmol/L] above baseline) was compared in the matched subgroups by using the Fisher exact test. A total of 12 508 propensity score-matched patients with contrast-enhanced and unenhanced scans met all inclusion criteria. In this predominantly inpatient cohort, the incidence of AKI significantly increased with decreasing baseline eGFR (P < .0001). However, this incidence was not significantly different between contrast material and non-contrast material groups in any eGFR subgroup; for the subgroup with eGFR of 90 or greater (n = 1642), odds ratio (OR) was 0.91 (95% confidence interval [CI]: 0.38, 2.15), P = .82; for the subgroup with eGFR of 60-89 (n = 3870), OR was 1.03 (95% CI: 0.66, 1.60), P = .99; for the subgroup with eGFR of 30-59 (n = 5510), OR was 0.94 (95% CI: 0.76, 1.18), P = .65; and for the subgroup with eGFR of less than 30 mL/min/1.73 m(2) (n = 1486), OR was 0.97 (95% CI: 0.72, 1.30), P = .89. Diminished eGFR is associated with an increased risk of SCr-defined AKI following CT examinations. However, the risk of AKI is independent of contrast material exposure, even in patients with eGFR of less than 30 mL/min/1.73 m(2).Keywords
This publication has 21 references indexed in Scilit:
- Contrast Material–induced Nephrotoxicity and Intravenous Low-Osmolality Iodinated Contrast MaterialRadiology, 2013
- Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelinesEuropean Radiology, 2011
- Baseline incidence and severity of renal insufficiency evaluated by estimated glomerular filtration rates in patients scheduled for contrast-enhanced CTActa Radiologica, 2011
- Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does Not Increase the Risk of Contrast-Induced NephropathyAmerican Journal of Neuroradiology, 2009
- Contrast-Induced Nephropathy after Intravenous Administration: Fact or Fiction?Radiologic Clinics of North America, 2009
- Incidence and Outcomes of Contrast-Induced AKI Following Computed TomographyClinical Journal of the American Society of Nephrology, 2008
- The PREDICT Study: A Randomized Double-Blind Comparison of Contrast-Induced Nephropathy After Low- or Isoosmolar Contrast Agent ExposureAmerican Journal of Roentgenology, 2008
- A Comparison of Prediction Equations for Estimating Glomerular Filtration Rate in Adults without Kidney DiseaseJournal of the American Society of Nephrology, 2003
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Improved Observational Method for Studying Therapeutic EfficacyJAMA, 1981